Problem – The Drug Discovery Crisis
Traditional Drug Discovery& Development is Slow & Costly
- High Failure Rates & Costs: Traditional drug development takes 10+ years, costs billions, and has a 90% failure rate due to isolated target discovery and inefficient preclinical processes.
- Complex Diseases, Single-Target Limitations: Chronic conditions like fibrosis, cancer, and cardiovascular diseases require multi-target approaches, but conventional models often fall short.
- Limited Predictive Power: Existing preclinical models often fail to accurately predict human outcomes, leading to late-stage clinical trial failures.
- Manufacturing & Scale-Up Challenges: Translating lab success to clinical use is hindered by complex manufacturing, high costs, and long timelines.
- Need for Speed & Innovation: There is an urgent demand for faster, cost-effective drug development with higher success rates to meet critical patient needs.
Revolutionizing Drug Discovery and Development with Encure
Our Technology
Encure Bio's Revolutionary Drug Discovery & Development Solution:
Encure Biotherapeutics combines AI, quantum mechanics, and advanced pharmacology to revolutionize drug discovery, optimizing every stage from target identification to clinical translation.
- End-to-End AI Platform: Transforming drug discovery with seamless integration from target identification to clinical trials.
- Advanced Analytics: Leveraging multi-target discovery through systems pharmacology and cloud-based HTD for rapid lead optimization.
- Quantum Mechanics Integration: Enhancing molecular modeling accuracy for precise drug-receptor interactions.
- AI with Expert Scientific Team: Minimizing data errors and improving efficiency through a human-AI hybrid approach, reducing clinical trial attrition.
- Enhanced Drug Safety and Efficacy: Ensuring higher clinical success with improved safety, efficacy, and minimized toxicity.
- Innovative Formulations: Pioneering advanced delivery systems for biologics and oral biologics.
- Human Organoids & Animal Study Advancements: Accelerating preclinical validation with predictive disease models for novel target identification and AI-human hybrid-mediated drug-like substance validation to ensure clinical trial success.
- Smart Manufacturing: Robotics-driven precision and scalability for efficient scale-up and tech transfer.
- Global Impact: Strategic partnerships with industry leaders to accelerate innovation and bring next-generation therapies to patients faster and more affordably.
Our mission is to optimize drug delivery, boost clinical success rates, and improve affordability, bringing life-changing therapies to patients with unmatched speed and efficiency.
